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Abstract
Cribriform is a histopathological term used to describe a neo-
plastic epithelial proliferation in the form of large nests perforated
by many quite rounded different-sized spaces. This growth pattern
may be seen in carcinomas arising in different organs, and shows
important prognostic implications. Therefore, recent data in liter-
ature suggest that cribriform carcinoma is a histologically and
clinically distinctive type of tumour that should be separated from
other similar tumour types. In this article, the pathology of cribri-
form adenocarcinoma of the prostate, lung, breast, stomach, colon,
thyroid, and skin is discussed with particular reference to morpho-
logic and immunohistochemical features, differential diagnosis,
and clinical behaviour.
Introduction
In histopathology practice, the term cribriform (from the
ancient Latin cribrum i.e. sieve) refers to neoplasms showing an
architectural pattern of growth made up of straight packed glands
endowed with unequally distributed lumina, lacking interposed
stromal tissue (Figure 1).¹ A cribriform pattern has been identified
in invasive neoplasms arising in different organs.2-7 Recently,
cribriform neoplasms have been reclassified as more aggressive
entities than previously reported (e.g., carcinoma of the lung,
prostate, stomach, and colon).4,8-11 Therefore, the identification of
a cribriform pattern may have practical prognostic implications
for pathologists and oncologists.1 Our aim is to review morpho-
logical and immunohistochemical features, as well as discuss the
differential diagnosis, and prognostic implications of this histolog-
ic type. 
Cribriform pattern in invasive prostate cancer
Several studies have demonstrated that a cribriform pattern in
radical prostatectomy specimens was associated with extraprosta-
tic extension, positive surgical margins, distant metastases, and
cancer-specific mortality.7,12,13 In 2005, the International Society
of Urological Pathology (ISUP) assigned a Gleason grade 4 rather
than Gleason grade 3 for a cribriform pattern.8,9 In 2009, Lotan et
al showed that there was often histologic continuity between
glomeruloid glands and cribriform pattern.14 Glomeruloid pattern
is a term used to describe dilated glands containing intraluminal
cribriform structures with a single point of attachment, reminis-
cent of a renal glomerulus.7,14 Two recent studies suggest that
glomeruloid structures could be considered as an early stage of
cribriform Gleason pattern 4.14 Moreover, Lotan et al. showed that
84% of cases with glomeruloid glands were associated with
Gleason grade 4, or higher, cancer.14 At the 2014 ISUP grading
conference, assigned for glomeruloid pattern was assigned a
Gleason grade 4.7 Solid nests or cribriform structures with come-
donecrosis are considered Gleason pattern 5.7 
The differential diagnosis for atypical cribriform lesions of the
prostate has become increasingly complex and includes intraduc-
tal carcinoma of the prostate (IDC-P), high-grade prostatic
intraepithelial neoplasia (HG-PIN), ductal carcinoma, and acinar
cell carcinoma with cribriform pattern.15,16 Invasive acinar adeno-
carcinoma may closely mimic IDC-P when it has a cribriform or
solid architecture. The key difference between IDC-P and invasive
acinar adenocarcinoma with cribriform/glomeruloid pattern is a
lack of any basal cell layer present in invasive acinar adenocarci-
noma.7,15,17,18 IDC-P must be distinguished from HG-PIN.
Usually, in HG-PIN tumour cells are uniformly atypical with
nuclear size 2-3 times normal adjacent nuclei, whereas in IDC–P
there is a marked pleomorphism with nuclear size >6 times normal
adjacent nuclei.15,17,19,20 Moreover, HG-PIN involves few glands,
whereas IDC-P frequently involves >6 glands.15 Comedonecrosis
and mitoses are rarely seen in HG-PIN, whereas they are easily
identifiable in IDC-P.15,17-20 Immunohistochemical staining for
PTEN may be useful in difficult cases, as it remains positive in
HG-PN and is negative in IDC-P.15,18,20,21 Table 1 summarizes the
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morphologic and immunohistochemical features that are useful in
the differential diagnosis between HG-PIN, IDC-P, ductal carcino-
ma and acinar cell carcinoma with cribriform architecture. 
Invasive cribriform carcinoma of the breast
Invasive cribriform carcinoma is a rare histological type of
invasive breast cancer accounting for less than 4% of all breast
cancers.3,22,23 Histologically, it is characterized by angulated
epithelial nests composed of mild to moderate atypical cells
arranged in a sieve-like pattern, which are surrounded by a
fibrosclerotic stroma.3 Typically, neoplastic cells with apical
snouts as well as lumina occupied by microcalcification and
mucin-like substance can be recognized.3,24 Immunohisto -
chemically, cancerous nests are positive for cytokeratins, and
strongly for estrogen, as well as for progesteron receptors, but
myoepithelial markers such as p63 and smooth muscle actin are
not expressed.24 Breast invasive cribriform carcinoma is subdivid-
ed into three forms: the pure invasive type (whenever >90% of a
cribriform pattern of the entire lesion), the invasive type (i.e., crib-
riform pattern plus a component of tubular carcinoma <50%), and
the mixed type (characterized by 10-49% of a carcinoma with his-
totype other than tubular).3 Generally, this neoplasm has a better
prognosis compared to invasive carcinoma of no special type (10-
year overall survival results between 90% and 100%) even if the
mixed type showed a worse prognosis between the two forms.3,24
Pleomorphism is minimal or absent, and nuclear grade I is present
in at least 90% of cells. Mitotic figures are unusual. According to
biomolecular classification of breast neoplasms, invasive cribri-
form carcinoma is mainly of the luminal A-type (luminal B-type
has also been described), since estrogen and progesteron receptors
are positively immunoexpressed in contrast to a negative hyperex-
pression/amplification for Her2 receptors.3,22,24
Table 2 shows the main differential diagnostic considerations
on adenoid cystic carcinoma, neuroendocrine tumours, and cribri-
form ductal carcinoma in situ and invasive.3,23,25-27
Cribriform pattern in lung adenocarcinoma
Histology-based 2015 World Health Organization (WHO)
classification of lung tumours identifies five histotypes: e.g., lep-
idic, acinar, papillary, micropapillary, and solid, whereas a cribri-
form pattern is considered a rare variant of the acinar adenocarci-
noma.5,10 Warth et al identified predominant and minor patterns of
lepidic, acinar, micropapillary, solid and cribriform components in
a series of 674 resected adenocarcinomas.28 Only 28 cases (4.2%)
were cribriform predominant, although a minor component was
frequently observed (28.6% of all cases).28 Moreover, a cribriform
pattern must be distinguished by metastatic cribriform neoplasms
of other sites, including breast, prostate, ovary, pancreas, uterus,
colon, and thyroid. Histologically, primary cribriform adenocarci-
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Table 1. Differential diagnosis among cribriform neoplasms of the prostate.
      HGPIN                      IDC-P                                          Ductal carcinoma       Acinar carcinoma 
                                                                                                                                (cribriform pattern)
Growth pattern                      Usually micropapillary                         Solid/dense cribriform     Papillary, solid or cribriform with      Cribriform and glomeruloid
       or loose cribriform.      or Loose cribriform/                             slitlike spaces                     pattern (Gleason pattern 4) 
                                                  micropapillary                                         (endometrioid pattern)    
Comedonecrosis                   No                                                              Frequent non-focal             Present                                                     Present in Gleason pattern 5 
                                                                                                                                                                      (invasive cribriform carcinoma)
Basal cell layer                       Intact or fragmented                            At least partial                     Absent                                                       Absent
Gland size                                Similar to adjacent normal glands     Expanded, branching         Large gland                                              Small glands
Cytological features              Cuboidal                                                   Cuboidal cells                      Tall columnar cells                                 Cuboidal cells
Nuclear features                   2-3 times normal                                    >6 times normal                 Elongated                                                 Enlarged
Nucleoli                                   Prominent                                               Prominent                             Prominent                                                Prominent
Mitoses                                    Rare                                                          Few/frequent                       Frequent                                                  Frequent
Immunohistochemistry                                                                                                                                                                                              
       PSA                                    Positive                                                     Positive                                  Positive                                                     Positive
       AMACR                             Positive                                                     Positive                                  Positive                                                     Positive
       PTEN                                 Positive                                                     Negative in 61-84%              Negative                                                   Data unavailable
       Basal markers                Positive                                                     Positive                                  Negative                                                   Negative
Figure 1. Gastric carcinoma with a cribriform component. Note
nests of epithelial cells with round spaces producing cribriform
pattern (Hematoxylin and eosin staining; magnification, x100).
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nomas could show structures similar to: i) cribriform prostatic or
breast adenocarcinomas, such as roman bridges and comedonecro-
sis; ii) mucinous adenocarcinomas of the pancreas or ovary such as
garland-like distribution at the tumour periphery; iii) endometrioid
adenocarcinomas such as subnuclear vacuoles and comedonecro-
sis; iv) colorectal adenocarcinomas such as dirty necrosis and scat-
tered goblet cells; v) papillary thyroid carcinoma such as clearing
of nuclear chromatin and overlapping of the nuclei.10 However, a
primary lung phenotype can be confirmed by immunohistochem-
istry (i.e., TTF1+/CK7+/napsin A+) and negative results for other
markers.5,10,29
The correlation between cribriform predominant pattern and
ALK expression, EGFR or KRAS mutations is a controversial
issue. Mackinnon was unable to find a specific molecular signature
for cribriform predominant carcinomas, whereas Warth et al.
showed high rates of KRAS and no EGFR mutations.10,28 ALK-
positive pulmonary adenocarcinomas were more frequently
observed in tumours characterized by mixed growth pattern
including acinar, solid, micropapillary, and cribriform.10,28,30 Due
to its rarity and controversy over classification, further studies are
needed to verify specific associations of molecular signatures with
a cribriform pattern. Recent studies suggest that cribriform pattern
is associated with aggressive behavior.5,10 Kadota et al. showed
that cribriform predominant adenocarcinoma is characterized by a
higher mitotic rate, vascular invasion, and tissue necrosis com-
pared to acinar predominant adenocarcinoma.1 In particular, Warth
et al. showed that cribriform histotype heavily influences outcome,
and propose that a cribriform pattern would be better included in
high-grade tumours such as solid and micropapillary patterns
rather than in the acinar group, as currently suggested by WHO
classification.28 Based on promising data demonstrating peculiar
clinicopathologic features, several authors suggest the identifica-
tion of a cribriform pattern as a specific histotype in future WHO
lung tumours classifications.
Cribriform-morular variant of papillary thyroid
carcinoma
This name is referred to a rare variant of papillary thyroid car-
cinoma (corresponding to less than 0.5% of whole papillary thy-
roid carcinomas) that occurs sporadically, mainly in young
women, or in association with FAP or Gardner syndrome, which,
in the last WHO classification of endocrine tumours, is denominat-
ed simply cribriform carcinoma.6,31,32 The prognosis as well as the
biomolecular alterations (i.e., presence of RET/PTC translocation,
and no BRAF mutations) are similar to those discovered in classi-
cal papillary thyroid carcinoma.6 Histological findings of this
tumour other than the cribriform pattern of growth are: cuboidal to
columnar shaped cells, the observation of intratumoral squamoid
islands called morules (although they are squamous in morpholo-
gy, they are devoid of keratinization or of cellular bridges), the
eosinophilic biotin-containing inclusion of some nuclei localized
within the morules, hyperchromatic/pseudostratified nuclei, focal
nuclei with hallmark of papillary carcinoma (i.e., clearing,
grooves, intranuclear cytoplasmic inclusions), absence or scarcity
of colloid, lack of mitotic activity and necrosis, and encapsulated
well circumscribed edges with or without capsular and/or vascular
invasion.6,31-35 Immunohistochemically, neoplastic follicular cells
are stained with antibodies against thyroglobulin (although with
variable results), as well as for CK19 and TTF-1.31-33,36
Intriguingly, the morular cells express CA-19.9 and CD10, whilst
they are immunonegative for epithelial membrane antigen, high
molecular weight cytokeratins, and vimentin.32 An aberrant
nuclear expression for betacatenin evidences an alteration in
APC/Wnt pathway.32 The main differential diagnosis is between
the tall and columnar cells variant of papillary thyroid carcino-
ma.32,33 Tall cell variant shows neoplastic cells with heights at least
three times more compared to their widths, mainly papillary pat-
tern of growth, lack of cribriform as well as morular structures, dif-
fuse nuclear alterations typical of classical papillary thyroid carci-
noma, basally located nuclei, necrotic areas, mitotic activity, dif-
fuse immunostaining for thyroglobulin, detection of BRAF muta-
tion, major incidence in older men, and, aggressive behavior.6,31-33
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Table 2. Differential diagnosis of invasive cribriform carcinoma of the breast.
Histological type                         Microscopy                                                                    Immunohistochemistry
Adenoid cystic carcinoma                      Round-shaped spaces containing dPAS positive basement      cKit positive cells;
                                                                     membrane-like substance surrounded by two cell types         p63, calponin, CK 5/6 positive myoepithelial cells 
                                                                     (myoepithelial basaloid and eosinophilic cells)                          Estrogen and progesterone receptors generally negative
                                                                     No ductal carcinoma in situ                                                              
Invasive neuroendocrine tumours      Nests/trabeculae of spindle, plasmacytoid                                   Synaptophysin and chromogranin positivity
                                                                     or large clear cells                                                                              
Cribriform adenocarcinoma                  Absence of dPAS positive cores                                                       No cKit positivity
                                                                     Ductal carcinoma in situ may be present                                      Myoepithelial cells absent on immunohistochemical stains
                                                                                                                                                                                      Estrogen and progesterone receptors positive
Cribriform ductal carcinoma in situ    Presence of surrounding myoepithelial cells                              P63, calponin, CK 5/6 positive myoepithelial cells
Figure 2. Cribriform gastric carcinoma with tripolar mitosis
(Hematoxylin and eosin staining; magnification, x400).
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Instead, the columnar variant is typically characterized by supra
and/or subnuclear vacuolization of pseudostratified hyperchromat-
ic elongated cells, resembling those observed in early secretive
stage of endometrial glands, which are well decorated by TTF1
antigen, but variably for thyroglobulin.6,31,32 Moreover this variant
of PTC is devoid of any cribriform-morular pattern, and shows an
aggressive behavior.31,33,34
Gastric carcinoma with cribriform component
A cribriform component in gastric adenocarcinoma morpho-
logically similar to mammary intraductal carcinoma, is a rare pat-
tern of growth recognized in this organ, which to date has been
described only in a small cohort of intestinal type adenocarcino-
mas by Lino-Silva et al.4 Moreover this histopathological pattern
was not described in the last WHO Classification of Tumours of
Gastrointestinal tract.37 Gastric carcinoma with a cribriform com-
ponent is mainly diagnosed in adult men in an age similar to that
observed for common gastric adenocarcinoma, always associated
with an intestinal type carcinoma component, and not correlated
with histological hallmarks of Helicobacter pylori infection in the
adjacent mucosa (e.g., follicular gastritis, gastric atrophy, intestinal
metaplasia).4 Furthermore, gastric carcinoma with a cribriform
pattern shows a major tendency to possess a higher stage, lympho-
vascular and perineural invasion, and a lower disease free survival
rate, in comparison to conventional gastric carcinoma.4 Figure 2
shows a gastric carcinoma with a cribriform component character-
ized by atypical mitosis (Figure 2). From an immunohistochemical
viewpoint, tumour cells are diffusely decorated with CK7 and
CK19, but focally for CK20.4 Positivity for MUC5AC has also
been described, whereas the estrogen and progesterone receptors,
CDX2, MU1, MUC2, and GCDFP-15 are not expressed.4 The
most important differential diagnosis for gastric carcinoma with
cribriform component is with a metastatic breast cribriform carci-
noma.3,4 However, the presence of an in situ adenocarcinoma com-
ponent together with an immunonegative expression for the usual
markers of breast carcinoma such as mammoglobin, progesterone
and estrogen receptors, and GCDPF-15, are all useful elements for
diagnosing primitive gastric adenocarcinoma with cribriform com-
ponent.4
Colonic cribriform comedo-type adenocarcinoma
This histotype has been briefly described in the current WHO
Classification of Tumours of the Digestive System, and defined as
an adenocarcinoma in which is recognized a cribriform pattern
with a central area of comedo-like necrosis similar to that observed
in mammary intraductal carcinoma.2 Recently, a study by Lino-
Silva et al. has highlighted a negative outcome for this entity.11
Moreover, the majority of the cases enrolled in that study showed
adverse prognostic findings such as high stage, lymphovascular
invasion, lymph nodes metastasis in >5 of the harvested ones, and
lower 5-year survival than conventional adenocarcinomas histo-
type.11 Moreover, Kim et al. demonstrated a negative prognostic
impact for those colorectal carcinomas with a cribriform compo-
nent characterized by microsatellite instability high (MSI-H), in
terms of shorter disease-free survival.38
Primary cutaneous cribriform carcinoma
Cutaneous cribriform carcinoma, recently described in 1998, is
considered as a variant of sweat gland carcinoma, characterized by
excellent outcome without recurrence and/or metastasis.39,40 The
main histopathological findings of this tumour are the following: i)
partially or relatively well-circumscribed, non-encapsulated der-
mal nodule; ii) nests of epithelioid cells owning lumina; iii) pleo-
morphic elongated nuclei; iv) desmoplastic stroma; v) rare
mitoses; vi) none lymphovascular or perineural invasion.39,40
Immunohistochemical stains for CK5/6 and 7, CEA and EMA
(luminal), C-kit (CD117) BerEp4, and S100 reveal positivity in
tumour cells; CK20 invariably shows negativity.39 Primary cuta-
neous cribriform carcinoma should be distinguished from primary
cutaneous adenoid cystic carcinoma.39,40,41 However, the latter his-
tologic type is characterized by high recurrence risk, infiltrative
growth pattern, rare lymph node and lung metastases, perineural
infiltration.39,40,41 Moreover, the tumour consists of basaloid cells
surrounding hyaline, periodic acid-Schiff positive basement mem-
brane-like substance or alcian blue (pH 2.5) positive mucins.41
Immunohistochemistry is not helpful for the differential diagnosis
against cribriform carcinoma.
Conclusions
The diagnostic approach of pathologists in their daily practice
is based on the analysis of architectural and cytological features,
immunohistochemical stains and other ancillary techniques in the
contest of knowledge of the clinical background of the case.
Recently, cribriform pattern has emerged as a paradigmatic exam-
ple of an additional adverse prognostic factor in adenocarcinomas
of various organs, such as prostate, lung, stomach, colon. Instead,
patients with breast cribriform carcinoma have significantly better
survival rates than patients with invasive ductal cancer (not other-
wise specified), whereas the prognosis of a cribriform-morular
variant of papillary thyroid carcinoma is similar to that of classical
papillary thyroid carcinoma. Thus, cribriform carcinoma is not
only a morphologic tumour growth pattern, but also a prognostic
factor. More research is required to evaluate the prognostic impli-
cations of a diagnosis of cribriform carcinoma in other organs such
as in the skin. However, practicing pathologists should be aware
that cribriform tumours of prostate, lung, stomach and colon are
clinically aggressive, in order to diagnose and treat an affected
patient correctly.
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